[PHARMA] QoQ Cumulative Quarter Result on 31-Dec-2011 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
22-Feb-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
31-Dec-2011 [#4]
Profit Trend
QoQ- 29.7%
YoY- 71.66%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Revenue 1,329,942 903,482 446,745 1,520,981 1,153,195 781,763 385,328 127.87%
PBT 99,066 70,573 42,955 73,186 56,818 41,172 21,792 173.66%
Tax -28,392 -25,435 -13,894 -20,401 -16,215 -11,528 -6,193 175.20%
NP 70,674 45,138 29,061 52,785 40,603 29,644 15,599 173.05%
-
NP to SH 69,645 44,398 28,685 52,157 40,215 29,404 15,484 171.73%
-
Tax Rate 28.66% 36.04% 32.35% 27.88% 28.54% 28.00% 28.42% -
Total Cost 1,259,268 858,344 417,684 1,468,196 1,112,592 752,119 369,729 125.86%
-
Net Worth 496,623 481,282 474,161 514,273 464,307 451,381 437,661 8.76%
Dividend
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Div 29,420 17,650 8,824 35,304 - - - -
Div Payout % 42.24% 39.76% 30.76% 67.69% - - - -
Equity
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Net Worth 496,623 481,282 474,161 514,273 464,307 451,381 437,661 8.76%
NOSH 117,683 117,672 117,657 117,682 106,983 106,962 107,007 6.52%
Ratio Analysis
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
NP Margin 5.31% 5.00% 6.51% 3.47% 3.52% 3.79% 4.05% -
ROE 14.02% 9.22% 6.05% 10.14% 8.66% 6.51% 3.54% -
Per Share
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 1,130.10 767.79 379.70 1,292.44 1,077.92 730.88 360.09 113.91%
EPS 59.18 37.73 24.38 44.32 37.59 27.49 14.47 155.08%
DPS 25.00 15.00 7.50 30.00 0.00 0.00 0.00 -
NAPS 4.22 4.09 4.03 4.37 4.34 4.22 4.09 2.10%
Adjusted Per Share Value based on latest NOSH - 117,655
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 92.28 62.69 31.00 105.53 80.01 54.24 26.74 127.85%
EPS 4.83 3.08 1.99 3.62 2.79 2.04 1.07 172.38%
DPS 2.04 1.22 0.61 2.45 0.00 0.00 0.00 -
NAPS 0.3446 0.3339 0.329 0.3568 0.3222 0.3132 0.3037 8.76%
Price Multiplier on Financial Quarter End Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 -
Price 7.55 10.18 5.90 5.36 5.90 5.90 5.73 -
P/RPS 0.67 1.33 1.55 0.41 0.55 0.81 1.59 -43.70%
P/EPS 12.76 26.98 24.20 12.09 15.70 21.46 39.60 -52.90%
EY 7.84 3.71 4.13 8.27 6.37 4.66 2.53 112.11%
DY 3.31 1.47 1.27 5.60 0.00 0.00 0.00 -
P/NAPS 1.79 2.49 1.46 1.23 1.36 1.40 1.40 17.74%
Price Multiplier on Announcement Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 06/11/12 08/08/12 03/05/12 22/02/12 01/11/11 10/08/11 13/05/11 -
Price 8.25 8.83 5.90 5.90 5.90 5.90 5.05 -
P/RPS 0.73 1.15 1.55 0.46 0.55 0.81 1.40 -35.13%
P/EPS 13.94 23.40 24.20 13.31 15.70 21.46 34.90 -45.67%
EY 7.17 4.27 4.13 7.51 6.37 4.66 2.87 83.80%
DY 3.03 1.70 1.27 5.08 0.00 0.00 0.00 -
P/NAPS 1.95 2.16 1.46 1.35 1.36 1.40 1.23 35.84%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment